BioCentury
ARTICLE | Clinical News

A/H5N1 Avian Influenza Vaccine: Completed Phase I enrollment

August 6, 2012 7:00 AM UTC

Novavax completed enrollment in a pair of single-blind, placebo-controlled, dose-ranging, U.S. Phase I trials evaluating intramuscular A/H5N1Avian Influenza Vaccine given 21 days apart with or without...